Findings will benefit thousands of patients diagnosed worldwide with leukemia, other cancers and disorders
Two of the University of Minnesota Masonic Cancer Center's leading physician-scientists on research and treatment of cancers of the blood and bone marrow - Philip McGlave, M.D., and Jeffrey Miller, M.D., -- have received renewed five-year program project research grants totaling almost $26 million from the National Cancer Institute (NCI).
McGlave and Miller will use the grants to lead research teams focused on increasing the availability, safety, and effectiveness of hematopoietic stem cell transplantation and cell therapies to improve treatment and survival for the thousand of patients diagnosed annually with leukemia, lymphoma, multiple myeloma and other blood and bone marrow disorders.
Innovative urine test could improve pancreatic cancer survival rates